To assess if MDM2 regulates MYC proteins in such cancers, we examined effects of MDM2 knockdown in the MYCN-overexpressing SCLC cell lines H69 and H526 and the MYC-overexpressing H211 and H82, which are all TP53 mutant (32–35). Here, MDM2 is linked to cancer.